Original Article
Surveillance for Escherichia coli O157:H7 Infections in Minnesota by Molecular Subtyping
N Engl J Med 1997; 337:388-394August 7, 1997
- Abstract
Background
Escherichia coli O157:H7 is a leading cause of diarrhea and the hemolytic–uremic syndrome. Current public health surveillance for E. coli O157:H7 requires considerable resources; traditional methods lack the sensitivity and specificity to detect outbreaks effectively.
Methods
During 1994 and 1995, the Minnesota Department of Health requested that all clinical isolates of E. coli O157:H7 be submitted to our laboratory. Isolates were subtyped by pulsed-field gel electrophoresis (PFGE), and patients were interviewed about potential sources of infection.
Results
In 1994 and 1995, 344 cases of E. coli O157:H7 infection were reported to the Minnesota Department of Health; 317 (92 percent) were subtyped by PFGE, and 143 distinct PFGE patterns were identified. Ten outbreaks of E. coli O157:H7 were identified; these accounted for 56 (18 percent) of the 317 subtyped cases. Four outbreaks were detected solely as a result of subtype-specific surveillance. In 11 two-week periods, the number of reported cases of E. coli O157:H7 doubled from the previous two weeks. In eight of these instances, the patterns identified were dissimilar and there were no outbreaks. Two of the remaining three increases resulted from multiple simultaneous outbreaks.
Conclusions
Subtype-specific surveillance for E. coli O157:H7 can identify outbreaks that are not detected by traditional methods and can ascertain whether sudden increases in reported cases are due to sporadic isolated cases or to one or more outbreaks.
Media in This Article
Figure 1
Patterns on Pulsed-Field Gel Electrophoresis of E. coli O157:H7.Figure 3
Cases of E. coli O157:H7 Infection According to the Week of Onset (Top Panel) and According to the Pattern on Pulsed-Field Gel Electrophoresis (PFGE), Minnesota, 1995.Article Activity
- Article
Since Escherichia coli O157:H7 was identified as an enteric pathogen in 1982, it has been the subject of multiple-outbreak and other epidemiologic investigations.1 However, the molecular epidemiology and ecology of this organism in humans and animals still need to be defined more fully. For example, in 1994 and 1995, 64 outbreaks of E. coli O157:H7 were reported to the Centers for Disease Control and Prevention (CDC) (Sparling PH: personal communication). These outbreaks accounted for only 998 cases during this two-year period, as compared with the estimated 20,000 E. coli O157:H7 infections that occur annually in the United States.2 The remaining cases are probably sporadic or part of unrecognized outbreaks.
Molecular-subtyping methods have been developed to discriminate various strains of E. coli O157:H7.3-7 These methods have been applied primarily when there have been outbreaks, to distinguish between outbreak-associated and sporadic or unrelated infections. When there was a sudden increase in reported cases, subtyping was used to discriminate among isolates of E. coli O157:H7, helping the epidemiologic investigators to identify a common vehicle of infection.8 However, the value of isolate subtyping as a surveillance tool on a population basis is not known. We began routine molecular subtyping of E. coli O157:H7 isolates submitted to the Minnesota Department of Health in 1994 and 1995. The objectives of our study were to improve our understanding of the epidemiology of E. coli O157:H7 and to determine whether routine molecular subtyping of E. coli O157:H7 isolates is useful in public health practice.
Methods
Case Ascertainment
The reporting of E. coli O157:H7 infections to the Minnesota Department of Health became compulsory in 1987. In 1994 and the first three quarters of 1995, the department requested that all clinical laboratories in the state submit any E. coli O157:H7 isolates from Minnesota residents to the state public health laboratory for confirmation and molecular subtyping. Beginning in October 1995, submission of E. coli O157:H7 isolates was required under the Minnesota rules governing communicable diseases.
Patients were defined as sick people who resided in Minnesota and had E. coli O157:H7 isolated from a stool culture. They were identified through the submission of isolates from clinical laboratories or through direct reports from health care providers. Once isolates were confirmed as being E. coli O157:H7, the patients were interviewed by telephone; a standardized questionnaire was used to ascertain their history of diarrheal illness and any potential common exposures (e.g., attending a day-care center, drinking untreated water, consuming undercooked hamburger, and eating in restaurants). Interviews were conducted before the results of subtyping by pulsed-field gel electrophoresis (PFGE) became available, by interviewers who were not aware of the results.
The reporting of the hemolytic–uremic syndrome was required in Minnesota beginning in 1987. Patients were defined as Minnesota residents with the triad of microangiopathic hemolytic anemia (hematocrit <30 percent, with evidence of intravascular erythrocyte destruction on a peripheral-blood smear), thrombocytopenia (platelet count, <150,000 per cubic millimeter), and evidence of renal involvement (blood urea nitrogen, >20 mg per deciliter or abnormal urinary sediment). Patients were identified through an active–passive reporting system. The active component was based on routine contact with specialists in pediatric intensive care and infection-control practitioners at major tertiary care centers in the state. In addition, Minnesota physicians were encouraged to obtain stool cultures from all patients with the hemolytic–uremic syndrome for isolation of E. coli O157:H7.
Epidemiologic Analysis
Information collected for each patient included his or her name, age, sex, and place of residence; the molecular-subtype designation of the isolate; the “event date”; the presence or absence of the hemolytic–uremic syndrome; and whether the case was part of a recognized outbreak. The event date was defined as the earliest date for which recorded information was available about the onset of symptoms, the date of stool collection, or the date the specimen was received at the laboratory. To determine overall and age-specific rates of infection, population estimates were obtained from Minnesota Health Statistics, 1994. 9 Descriptive analyses were conducted by using EpiInfo, version 6.01 (CDC, Atlanta).
An outbreak was defined as two or more cases in separate households with a common epidemiologic exposure. A case cluster was defined as two or more cases involving the same subtype, occurring within two weeks of each other, for which no common source could be determined by epidemiologic investigation. Temporal increases in the number of cases were evaluated by comparing the number of cases detected during the current two-week period with the number of cases detected during the previous two-week period.
Molecular Subtyping
DNA Isolation and Restriction
Bacterial suspensions were made by emulsifying the growth from 24-hour sheep's-blood agar cultures (BHI, Becton Dickinson, Cockeysville, Md.) in physiologic saline and standardizing to 55 to 65 percent transmittance at 590 nm. The suspension was concentrated by centrifugation, resuspended in EET (100 mM EDTA, 10 mM ethylene glycol-bis[beta-aminoethyl ether]N,N,N',N'-tetraacetic acid, and 10 mM Tris; pH 8.0), and immobilized in 1.6 percent agarose (SeaPlaque, GTG; FMC Bioproducts, Rockland, Me.). Plugs were then treated with lysozyme (EET with 0.05 percent N-lauroylsarcosine [Sigma, St. Louis] and 200 μg of lysozyme per milliliter [Boehringer Mannheim, Indianapolis]) for four hours at 30°C, followed by proteinase K (EET with 1.0 percent sodium dodecyl sulfate and 1 mg of proteinase K per milliliter; Boehringer Mannheim) for at least six hours at 50°C and were washed four times with TE buffer (10 mM Tris, pH 8.0, and 1 mM EDTA) for 30 minutes. All the washing steps were conducted with rotation at 170 cycles per minute by using a 1.0-in.-diameter orbital stroke. Inserts were cut into lengthwise slices and restricted with Xba1 endonuclease in 100 μl of buffer H (Boehringer Mannheim; 30 units) for at least four hours at 37°C. Restricted slices were washed in 0.5× TBE (which consists of 5.4 g of Tris base per liter, 2.75 g of boric acid per liter, and 0.645 g of EDTA per liter) and loaded directly onto a 1 percent agarose gel (FastLane, FMC Bioproducts).
PFGE Conditions
DNA fragments were separated with a CHEF Mapper (Bio-Rad Laboratories, Hercules, Calif.). Lambda concatemers and Saccharomyces cerevisiae DNA (Boehringer Mannheim) were used as standards. Gels were run with the use of 0.5× TBE buffer at 14°C, a linear ramp of 12.56 to 40.09 seconds over a period of 24 hours, a 120-degree switch angle, and a gradient of 6.0 v per centimeter. The gels were then stained with 0.01 percent ethidium bromide solution (Sigma) and photographed with ultraviolet illumination from a fixed camera position.
Gel Analysis and Interpretation
Restriction-fragment patterns were initially matched by visual comparison and measurement of physical band migration relative to lambda and yeast standards. Gel photographs were subsequently digitized with a Photodoc 1000 System (Bio-Rad), and PFGE profiles were compared by using the Jaccard coefficient and Molecular Analyst Plus software (Bio-Rad). DNA patterns were screened with a 3 percent molecular weight–matching tolerance, and matches were confirmed visually. PFGE strains were defined as having exact matches of all bands in the 147-to-700-kb range. A single isolate representing each PFGE pattern was retested to verify its uniqueness and to establish run-to-run reproducibility. On each gel, an E. coli O157:H7 reference strain was used in three lanes as a process control (Figure 1Figure 1
Patterns on Pulsed-Field Gel Electrophoresis of E. coli O157:H7.).Results
Three hundred forty-four cases of E. coli O157:H7 infection were reported among Minnesota residents during 1994 (147 cases) and 1995 (197). The annual rate of reported infections among Minnesota residents over the two-year period was 3.8 per 100,000 person-years (Table 1Table 1
Number of Reported Cases and Age-Specific Incidence Rates for E. coli O157:H7 Infection and the Hemolytic–Uremic Syndrome in Minnesota, 1994 and 1995.). The age-specific rate of infection for children under the age of five years was 9.3 per 100,000 person-years.Isolates were received from 135 (92 percent) and 182 (92 percent) of the 1994 and 1995 patients, respectively (Table 2Table 2
Summary of Submissions of E. coli O157:H7 Isolates to the Minnesota Department of Health, 1994 and 1995.). Patients with isolates available for subtyping and those without were similar with respect to age (mean age, 28.3 and 25.7 years, respectively) and sex (48 percent and 46 percent male, respectively). One hundred forty-three distinct PFGE patterns were identified during the two-year period. Ninety-eight of these patterns (69 percent) were unique and occurred in only a single case isolate. Seventy-two different patterns were identified in 1994; 52 (72 percent) were unique. In 1995, 86 different patterns were identified; 59 (69 percent) were unique. The five most common patterns identified in 1994 and 1995 accounted for 109 of the total of 317 isolates (34 percent). Only 15 of the patterns (10 percent) identified in 1994 were also observed in 1995.The date of the onset of illness (266 patients) or of stool collection (44) was obtained for 310 (98 percent) of the 317 patients with available isolates. The date of receipt of the specimen at the laboratory was available for the remaining patients. In 53 percent of the 1994 cases and 60 percent of the 1995 cases, the onset of illness was between July and September (Figure 2Figure 2
Cases of E. coli O157:H7 Infection According to the Week of Onset (Top Panel), and According to the Pattern on Pulsed-Field Gel Electrophoresis (PFGE) (Bottom Panel), Minnesota, 1994. and Figure 3Figure 3Cases of E. coli O157:H7 Infection According to the Week of Onset (Top Panel) and According to the Pattern on Pulsed-Field Gel Electrophoresis (PFGE), Minnesota, 1995.). In both 1994 and 1995, the number of cases reported according to the week of onset varied sufficiently to suggest the possibility that some cases represented communitywide common-source outbreaks. During the two years of observation, there were 11 occasions when the number of E. coli O157:H7 cases reported within a two-week period was double the number in the previous two-week period. In eight of these instances, PFGE analysis demonstrated that the increases consisted of isolates with different PFGE patterns. Two of the remaining three increases were caused by multiple outbreaks with isolates of different PFGE patterns occurring simultaneously.Ten outbreaks with a common source were identified (Table 3Table 3
Confirmed E. coli O157:H7 Outbreaks in Minnesota, 1994 and 1995.). These 10 outbreaks accounted for only 56 (18 percent) of the 317 cases whose isolates were subtyped. Four outbreaks were associated with the consumption of hamburger from specific retail markets. Three outbreaks were associated with the consumption of contaminated water. The other outbreaks involved person-to-person transmission in a children's day-care facility, the consumption of contaminated coleslaw during a faculty meal at a college, and the consumption of contaminated roast beef at a church banquet. Four outbreaks were identified on the basis of subtyping data only, when a temporal cluster of identical subtypes initiated an epidemiologic investigation. Three were identified after notification by community agents such as county health departments or hospital infection-control practitioners. The remaining outbreaks were detected through a combination of reviews of subtyping data and concurrent interviews of patients with reported cases.In addition to the 10 outbreaks, 35 case clusters without recognized common sources were identified. These 35 clusters accounted for 94 (30 percent) of the 317 cases subtyped. Thirty (86 percent) of the 35 clusters involved three or fewer patients. In eight clusters, two patients resided in the same household.
Of the 10 outbreaks and 35 case clusters, 9 involved five or more isolates of an identical subtype pattern; a common source was identified in 6 (67 percent) of those. Conversely, of the 36 clusters involving two to four isolates with a single PFGE pattern, a common source was identified in only 4 (11 percent).
A high level of homogeneity was noted among isolates obtained from epidemiologically linked cases. Of the 56 cases identified as part of the 10 outbreaks recognized in 1994 and 1995, only 2 cases in 2 different outbreaks involved a PFGE pattern different from the recognized outbreak strain. Although these isolates differed from the outbreak strain by one band, they were closely related to it when evaluated according to the interpretive criteria proposed by Tenover et al.10
Twenty-five cases of the hemolytic–uremic syndrome were identified during the two-year period — 9 in 1994 and 16 in 1995. Fourteen patients (56 percent) had E. coli O157:H7 isolated from stool specimens. Eleven different E. coli O157:H7 patterns were recognized among these patients. No enteric pathogen was isolated from the other 11 patients. Twenty-two patients with the hemolytic–uremic syndrome (88 percent) were under 10 years of age, and 76 percent (19) were male. The annual age-specific rate of the hemolytic–uremic syndrome in children less than 10 years of age with documented E. coli O157:H7 infection was 1.2 per 100,000 person-years. Fifteen cases of the syndrome (60 percent) occurred in July, August, and September, reflecting the same seasonal trend as was documented for E. coli O157:H7 infections overall. The ratio of E. coli O157:H7 infections to cases of the hemolytic–uremic syndrome among children less than 10 years of age did not vary significantly according to the geographic area within the state. In the Minneapolis–St. Paul metropolitan area, there were 4.3 E. coli O157:H7 infections reported for each case of the hemolytic–uremic syndrome. Outside the metropolitan area, 5.2 cases of E. coli O157:H7 infection were reported for each case of the syndrome.
Discussion
We report here the results of molecular subtyping of E. coli O157:H7 isolates and the usefulness of this method in public health practice. Our major findings include the following. First, there was a marked heterogeneity of isolates, with 143 distinct PFGE patterns identified during the two-year study period. Second, subtyping provided a tool for determining whether or not an outbreak or multiple outbreaks were present when the number of cases increased. For most of the sudden increases in numbers of reported cases, there was no evidence of an outbreak when isolates were subtyped. Without the benefit of subtyping, investigations of similar increases in other areas of the country have led to unnecessary use of limited public health resources.8,11 In two instances in Minnesota, what originally appeared to be a single outbreak was subsequently recognized through subtyping to be multiple outbreaks occurring within a defined period. Third, subtype-specific surveillance allowed us to identify outbreaks that would not have been detected by traditional surveillance methods. Almost half the outbreaks documented (4 of 10) were identified by subtype-specific surveillance alone.
The heterogeneity of the E. coli O157:H7 patterns identified in our study has implications for efforts to prevent and control infections. Since most case clusters were small and many cases were sporadic, primary-prevention strategies must focus on reducing contamination of raw foods and changing behavior, particularly behavior related to food preparation and general hygiene.1,12,13
During the two-year period, over half the patients identified harbored E. coli isolates that had unique PFGE patterns. However, 30 percent of the patients had an E. coli isolate with a PFGE pattern that was isolated from at least one other person during the same two-week period but for which no epidemiologic association could be identified. Because cases involving E. coli isolates with similar PFGE patterns often clustered temporally, the data suggest that different E. coli strains may contaminate a common product and subsequently appear in the community where the product is distributed. Such outbreaks go unrecognized because relatively few cases are detected. Even if molecular subtyping is used on a statewide basis and multiple isolates with common PFGE patterns are identified, it may be difficult to determine the source if the numbers of cases are low, unless amplification occurs through other community exposures, such as the contamination of swimming beaches or transmission within child-care settings.14-17 For example, when a cluster of five or more cases of a single PFGE pattern was recognized, we found a common source 67 percent of the time. In contrast, when only two to four cases with the same pattern were identified, a common source was found only 11 percent of the time. These results suggest that the identification of outbreaks is unlikely when commercial products are distributed over a multistate area and few cases are identified in each state. Active subtype surveillance on a regional basis may be necessary to increase the likelihood of detecting such outbreaks, identifying the source, and taking appropriate public health action.
The large number of PFGE patterns found in this study can be attributed in part to the stringency of the definition of a strain. Strain relatedness, determined according to the interpretive criteria proposed by Tenover et al.,10 was not used to differentiate among PFGE patterns in this population-based study. As Tenover et al. state, their criteria for determining strain relatedness were designed for the evaluation of outbreaks of limited size and duration. Conversely, we believe that the interpretive criteria for strain matching of isolates obtained through population-based surveillance should be more restrictive to provide the specificity needed to relate apparently sporadic infections over a large geographic area. This approach is critical to the detection of outbreaks associated with widely distributed food products. Furthermore, our data indicate that PFGE patterns tend to be stable in outbreaks, although single-band differences were found in two instances among isolates from epidemiologically associated cases.
Using PFGE subtyping (or other subtyping methods as they become available) as a routine surveillance tool requires, first, a system for submitting and receiving isolates. In Minnesota, clinical laboratories are required to notify the Minnesota Department of Health of any pathogenic E. coli isolated within 24 hours of the completion of microbiologic cultures and to submit isolates to the state public health laboratory. Second, laboratory staff must be available at a central location to characterize isolates rapidly as they are submitted. Generally, results were available within five days when there was one full-time PFGE technician. It is also essential to have the epidemiologic capacity to investigate cases rapidly when identical PFGE patterns are identified. Although this system may seem expensive, much of the cost can be offset by not initiating epidemiologic investigations when the number of cases increases unless subtyping data support the possibility of a common source. Increasing the specificity of outbreak case definitions by the use of molecular subtyping can conserve resources by decreasing the amount of time spent on unnecessary and labor-intensive case–control studies.
Molecular subtyping of E. coli O157:H7 has revolutionized population-based surveillance for this organism in Minnesota. We now routinely subtype all E. coli O157:H7 isolates and consider this technique to be an integral part of disease prevention and control in our state. We are currently exploring similar subtyping approaches for other enteric and invasive bacterial pathogens, and we believe that such techniques will substantially improve other public health surveillance efforts, particularly at the state and regional levels.
Supported in part by a cooperative agreement (U50/CCU511190) with the CDC.
Source Information
From the Acute Disease Epidemiology Section (J.B.B., C.W.H., K.L.M., M.T.O.) and the Division of Public Health Laboratories (J.M.B., D.J.B.), Minnesota Department of Health, Minneapolis.
Address reprint requests to Dr. Bender at the Acute Disease Epidemiology Section, Minnesota Department of Health, 717 Delaware St. SE, Minneapolis, MN 55440-9441.
- References
References
1
Griffin PM ,Tauxe RV . The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev 1991;13:60-98
Web of Science | Medline2
Escherichia coli O157:H7 outbreak linked to commercially distributed dry-cured salami -- Washington and California, 1994MMWR Morb Mortal Wkly Rep 1995;44:157-160
Medline3
Banatvala N ,Magnano AR ,Cartter ML , et al. Meat grinders and molecular epidemiology: two supermarket outbreaks of Escherichia coli O157:H7 infection. J Infect Dis 1996;173:480-483
CrossRef | Web of Science | Medline4
Barrett TJ ,Lior H ,Green JH , et al. Laboratory investigation of a multistate food-borne outbreak of Escherichia coli O157:H7 by using pulsed-field gel electrophoresis and phage typing. J Clin Microbiol 1994;32:3013-3017
Web of Science | Medline5
Rodrigue DC ,Mast EE ,Greene KD , et al. A university outbreak of Escherichia coli O157:H7 infections associated with roast beef and an unusually benign clinical course. J Infect Dis 1995;172:1122-1125
CrossRef | Web of Science | Medline6
Krause U ,Thomson-Carter FM ,Pennington TH . Molecular epidemiology of Escherichia coli O157:H7 by pulsed-field gel electrophoresis and comparison with that by bacteriophage typing. J Clin Microbiol 1996;34:959-961
Web of Science | Medline7
Swaminathan B, Matar GM. Molecular typing methods. In: Persing DH, Smith TF, Tenover FC, White TJ, eds. Diagnostic molecular microbiology: principles and applications. Washington, D.C.: American Society for Microbiology, 1995:26-50.
8
Enhanced detection of sporadic Escherichia coli O157:H7 infections -- New Jersey, July 1994MMWR Morb Mortal Wkly Rep 1995;44:417-418
Medline9
Minnesota Health Statistics, 1994. Minneapolis: Center for Health Statistics, Minnesota Department of Health, 1996.
10
Tenover FC ,Arbeit RD ,Goering RV , et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-2239
Web of Science | Medline11
Shefer AM ,Koo D ,Werner SB , et al. A cluster of Escherichia coli O157:H7 infections with the hemolytic-uremic syndrome and death in California -- a mandate for improved surveillance. West J Med 1996;165:15-19
Medline12
Hedberg CW ,MacDonald KL ,Osterholm MT . Changing epidemiology of food-borne disease: a Minnesota perspective. Clin Infect Dis 1994;18:671-682
CrossRef | Web of Science | Medline13
Tarr PI . Escherichia coli O157:H7: clinical, diagnostic, and epidemiologic aspects of human infection. Clin Infect Dis 1995;20:1-10
CrossRef | Web of Science | Medline14
Ostroff SM ,Griffin PM ,Tauxe RV , et al. A statewide outbreak of Escherichia coli O157:H7 infections in Washington State. Am J Epidemiol 1990;132:239-247
Web of Science | Medline15
Besser RE ,Lett SM ,Weber JT , et al. An outbreak of diarrhea and hemolytic uremic syndrome from Escherichia coli O157:H7 in fresh-pressed apple cider. JAMA 1993;269:2217-2220
CrossRef | Web of Science | Medline16
Lake-associated outbreak of Escherichia coli O157:H7 -- Illinois, 1995MMWR Morb Mortal Wkly Rep 1996;45:437-439
Medline17
Belongia EA ,Osterholm MT ,Soler JT ,Ammend DA ,Braum JE ,MacDonald KL . Transmission of Escherichia coli O157:H7 infection in Minnesota child day-care facilities. JAMA 1993;269:883-888
CrossRef | Web of Science | Medline
- Citing Articles (47)
Citing Articles
1
J. M. ROUNDS, D. J. BOXRUD, S. L. JAWAHIR, K. E. SMITH. (2011) Dynamics of Escherichia coli O157:H7 outbreak detection and investigation, Minnesota 2000–2008. Epidemiology and Infection1-9
CrossRef2
Elizabeth J Elliott, Greta F Ridley, Elisabeth M Hodson, Jonathan C Craig, Elizabeth J Elliott. 2010. Interventions for preventing haemolytic uraemic syndrome/thrombotic thrombocytopenic purpura. .
CrossRef3
Dave Boxrud. (2010) Advances in subtyping methods of foodborne disease pathogens. Current Opinion in Biotechnology 21:2, 137-141
CrossRef4
Samuel K. Sheppard, Martin C. J. Maiden, Daniel Falush. 2010. Population Genetics of Campylobacter. , 181-194.
CrossRef5
Rubens C.S. Dias, Denise V. Marangoni, Sherry P. Smith, Elizabeth M. Alves, Flavia L.P.C. Pellegrino, Lee W. Riley, Beatriz M. Moreira. (2009) Clonal Composition of Escherichia coli Causing Community-Acquired Urinary Tract Infections in the State of Rio de Janeiro, Brazil. Microbial Drug Resistance 15:4, 303-308
CrossRef6
William A. Lanier, Molly M. Leeper, Kirk E. Smith, Glenn E. Tillman, Kristin G. Holt, Peter Gerner-Smidt. (2009) Pulsed-Field Gel Electrophoresis Subtypes of Shiga Toxin–Producing Escherichia coli O157 Isolated from Ground Beef and Humans, United States, 2001–2006. Foodborne Pathogens and Disease 6:9, 1075-1082
CrossRef7
Amee R. Manges, Patricia A. Tellis, Caroline Vincent, Kimberley Lifeso, Geneviève Geneau, Richard J. Reid-Smith, Patrick Boerlin. (2009) Multi-locus variable number tandem repeat analysis for Escherichia coli causing extraintestinal infections. Journal of Microbiological Methods 79:2, 211-213
CrossRef8
Mini Michael, Elizabeth J Elliott, Greta F Ridley, Elisabeth M Hodson, Jonathan C Craig, Mini Michael. 2009. Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura. .
CrossRef9
William E Bennett, Phillip I Tarr. (2009) Enteric infections and diagnostic testing. Current Opinion in Gastroenterology 25:1, 1-7
CrossRef10
Fang Liu, Wenying Guan, MJ. Alam, Zhixin Shen, Shuhong Zhang, Lin Li, Sumio Shinoda, Lei Shi. (2009) Pulsed-field Gel Electrophoresis Typing of Multidrug-resistant Vibrio parahaemolyticus Isolated from Various Sources of Seafood. JOURNAL OF HEALTH SCIENCE 55:5, 783-789
CrossRef11
Jeong-Chi Lee, Min Ji Kim. (2009) Epidemiological Analysis of Shiga Toxin-producing E. coli Isolated in Gwangju, Korea, by Pulse-field Gel Electrophoresis. Journal of Bacteriology and Virology 39:3, 195
CrossRef12
Kara L. F. Cooper, Duncan R. MacCannell, Efrain M. Ribot. 2008. Pulsenet: A Program to Detect and Track Food Contamination Events. .
CrossRef13
S. Suzuki, N. Shibata, K. Yamane, J.-i. Wachino, K. Ito, Y. Arakawa. (2008) Change in the prevalence of extended-spectrum- -lactamase-producing Escherichia coli in Japan by clonal spread. Journal of Antimicrobial Chemotherapy 63:1, 72-79
CrossRef14
Amee R. Manges, Sherry P. Smith, Briana J. Lau, Christaline J. Nuval, Joseph N.S. Eisenberg, Peter S. Dietrich, Lee W. Riley. (2007) Retail Meat Consumption and the Acquisition of Antimicrobial Resistant Escherichia coli Causing Urinary Tract Infections: A Case–Control Study. Foodborne Pathogens and Disease 4:4, 419-431
CrossRef15
A. Mukherjee, S. Cho, J. Scheftel, S. Jawahir, K. Smith, F. Diez-Gonzalez. (2006) Soil survival of Escherichia coli O157:H7 acquired by a child from garden soil recently fertilized with cattle manure. Journal of Applied Microbiology 101:2, 429-436
CrossRef16
Amee R. Manges, Françoise Perdreau-Remington, Owen Solberg, Lee W. Riley. (2006) Multidrug-resistant Escherichia coli clonal groups causing community-acquired bloodstream infections. Journal of Infection 53:1, 25-29
CrossRef17
Gary Reiss, Pamela Kunz, Diana Koin, Emmet B. Keeffe. (2006) Escherichia Coli O157:H7 Infection in Nursing Homes: Review of Literature and Report of Recent Outbreak. Journal of the American Geriatrics Society 54:4, 680-684
CrossRef18
Craig W. Hedberg, John M. Besser. (2006) Commentary: Cluster Evaluation, PulseNet, and Public Health Practice. Foodborne Pathogens and Disease 3:1, 32-35
CrossRef19
Robert V. Tauxe. (2006) Molecular Subtyping and the Transformation of Public Health. Foodborne Pathogens and Disease 3:1, 4-8
CrossRef20
C. R. Braden, R. V. Tauxe. 2006. Surveillance for emerging pathogens in the United States. , 23-49.
CrossRef21
A. M. France, C. F. Marrs, L. Zhang, B. Foxman. (2005) Reply to Riley and Manges and to Johnson. Clinical Infectious Diseases 41:4, 568-570
CrossRef22
Christina Welinder-Olsson, Bertil Kaijser. (2005) Enterohemorrhagic Escherichia coli (EHEC). Scandinavian Journal of Infectious Diseases 37:6-7, 405-416
CrossRef23
Phillip I Tarr, Carrie A Gordon, Wayne L Chandler. (2005) Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. The Lancet 365:9464, 1073-1086
CrossRef24
M. Ramchandani, A. R. Manges, C. DebRoy, S. P. Smith, J. R. Johnson, L. W. Riley. (2005) Possible Animal Origin of Human-Associated, Multidrug-Resistant, Uropathogenic Escherichia coli. Clinical Infectious Diseases 40:2, 251-257
CrossRef25
M. T. Jay, V. Garrett, J. C. Mohle-Boetani, M. Barros, J. A. Farrar, R. Rios, S. Abbott, R. Sowadsky, K. Komatsu, R. Mandrell, J. Sobel, S. B. Werner. (2004) A Multistate Outbreak of Escherichia coli O157:H7 Infection Linked to Consumption of Beef Tacos at a Fast-Food Restaurant Chain. Clinical Infectious Diseases 39:1, 1-7
CrossRef26
John R. Dunn, James E. Keen, R. Alex Thompson. (2004) Prevalence of shiga-toxigenic Escherichia coli O157:H7 in adult dairy cattle. Journal of the American Veterinary Medical Association 224:7, 1151-1158
CrossRef27
Amee R. Manges, Peter S. Dietrich, Lee W. Riley. (2004) Multidrug‐Resistant Escherichia coli Clonal Groups Causing Community‐Acquired Pyelonephritis. Clinical Infectious Diseases 38:3, 329-334
CrossRef28
Gary R. Kravitz, Kirk Smith, Liz Wagstrom. (2002) Colonic Necrosis and Perforation Secondary to Escherichia coli O157:H7 Gastroenteritis in an Adult Patient without Hemolytic Uremic Syndrome. Clinical Infectious Diseases 35:9, e103-e105
CrossRef29
Elizabeth J Elliott, Greta F Ridley, Elisabeth M Hodson, Jonathan C Craig, Elizabeth J Elliott. 2002. Interventions for preventing haemolytic uraemic syndrome/thrombotic thrombocytopenic purpura. .
CrossRef30
E Elliott, G Ridley, E Hodson, J Craig, Jonathan Craig. 2002. Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura. .
CrossRef31
SATHAPORN MANATSATHIT, HERBERT L DUPONT, MICHAEL FARTHING, CHOMSRI KOSITCHAIWAT, SOMCHAI LEELAKUSOLVONG, BS RAMAKRISHNA, ADERBAL SABRA, PETER SPEELMAN, SURAPOL SURANGSRIRAT. (2002) Guideline for the management of acute diarrhea in adults. Journal of Gastroenterology and Hepatology 17, S54-S71
CrossRef32
Stamm, Walter E., . (2001) An Epidemic of Urinary Tract Infections?. New England Journal of Medicine 345:14, 1055-1057
Full Text33
Manges, Amee R., Johnson, James R., Foxman, Betsy, O'Bryan, Timothy T.Fullerton, Kathleen E., Riley, Lee W., . (2001) Widespread Distribution of Urinary Tract Infections Caused by a Multidrug-Resistant Escherichia coli Clonal Group. New England Journal of Medicine 345:14, 1007-1013
Full Text34
Phillip I. Tarr, Marguerite A. Neill. (2001) Escherichia coli O157:H7. Gastroenterology Clinics of North America 30:3, 735-751
CrossRef35
Bender, Jeffrey B., Hedberg, Craig W., Boxrud, David J., Besser, John M., Wicklund, Julie H., Smith, Kirk E., Osterholm, Michael T., . (2001) Use of Molecular Subtyping in Surveillance for Salmonella enterica Serotype Typhimurium. New England Journal of Medicine 344:3, 189-195
Full Text36
Wm Lane Robson. (2000) Haemolytic Uraemic Syndrome. Paediatric Drugs 2:4, 243-252
CrossRef37
Almut Liesegang, Ulrich Sachse, Rita Prager, Hermann Claus, Hartmut Steinrück, Stojanka Aleksic, Wolfgang Rabsch, Wolfgang Voigt, Angelika Fruth, Helge Karch, Jochen Bockemühl, Helmut Tschäpe. (2000) Clonal diversity of Shiga toxin-producing Escherichia coli O157:H7/H- in Germany — A ten-year study. International Journal of Medical Microbiology 290:3, 269-278
CrossRef38
Jenifer L. Jaeger, David W. K. Acheson. (2000) Shiga toxin-producing Escherichia coli. Current Infectious Disease Reports 2:1, 61-67
CrossRef39
Carol A Phillips. (1999) The epidemiology, detection and control ofEscherichia coli O157. Journal of the Science of Food and Agriculture 79:11, 1367-1381
CrossRef40
Howard Trachtman, Erica Christen. (1999) Pathogenesis, treatment, and therapeutic trials in hemolytic uremic sydrome. Current Opinion in Pediatrics 11:2, 162-168
CrossRef41
Hutin, Yvan J.F., Pool, Vitali, Cramer, Elaine H., Nainan, Omana V., Weth, Jo, Williams, Ian T., Goldstein, Susan T., Gensheimer, Kathleen F., Bell, Beth P., Shapiro, Craig N., Alter, Miriam J., Margolis, Harold S., . (1999) A Multistate, Foodborne Outbreak of Hepatitis A. New England Journal of Medicine 340:8, 595-602
Full Text42
Richard E. Besser, MD, Patricia M. Griffin, MD, Laurence Slutsker, MD, MPH. (1999) ESCHERICHIA COLI O157:H7 GASTROENTERITIS AND THE HEMOLYTIC UREMIC SYNDROME: An Emerging Infectious Disease 1. Annual Review of Medicine 50:1, 355-367
CrossRef43
Katharina Grif, Helge Karch, Christian Schneider, FranzD Daschner, Lothar Beutin, Thomas Cheasty, Henry Smith, Bernard Rowe, ManfredP Dierich, Franz Allerberger. (1998) Comparative study of five different techniques for epidemiological typing of Escherichia coli O157. Diagnostic Microbiology and Infectious Disease 32:3, 165-176
CrossRef44
Paul S Mead, Patricia M Griffin. (1998) Escherichia coli O157:H7. The Lancet 352:9135, 1207-1212
CrossRef45
Bryn Duffy, Chad Schwietert, Alex France, Niti Mann, Krista Culbertson, Benjamin Harmon, John P. McCue. (1998) Transition metals as protease inhibitors. Biological Trace Element Research 64:1-3, 197-213
CrossRef46
Wilkie F. Harrigan. (1998) Incidents of food poisoning and food-borne diseases from 'new' or 'unexpected' causes: can they be prevented?. International Journal of Food Science and Technology 33:2, 177-189
CrossRef47
James B Kaper. (1998) Enterohemorrhagic Escherichia coli. Current Opinion in Microbiology 1:1, 103-108
CrossRef
